Objectives: To clarify the influence of naftopidil, an α1D/A -adrenergic receptor antagonist, on the autonomic nervous system, we examined the relation between lower urinary tract symptoms (LUTS) and the plasma monoamine levels before and after naftopidil treatment in benign prostatic hyperplasia (BPH) patients.
Methods: A total of 43 patients with BPH were studied. The frequency of urination, international prostate symptom score (IPSS), quality of life (QOL) index, overactive bladder symptom score (OABSS), and plasma monoamine levels (adrenaline, noradrenaline, dopamine, and serotonin) were evaluated before and after naftopidil treatment.
Results: Naftopidil significantly improved urinary frequency in daytime and nighttime, IPSS, QOL index and OABSS in all patients, and decreased the plasma adrenaline level at 8 weeks. When the patients were divided into two groups based on the median adrenaline level (40.5 pg/mL) before treatment, urinary frequency in daytime and/or nighttime, incomplete emptying and poor flow in the IPSS, and the QOL index were significantly improved in the high adrenaline (HA) group, but not in the low adrenaline (LA) group. The pretreatment plasma serotonin level was significantly lower in the HA group than in the LA group, but it increased gradually after the start of treatment until there was no difference between the groups.
Conclusions: The modulation of plasma adrenaline and serotonin levels by naftopidil in patients with increased sympathetic activity contributed to improvement of LUTS associated with BPH, in addition to its antagonistic effects of α1D/A -adrenergic receptor on the detrusor and prostatic urethral smooth muscle, the urothelium, and the central nervous system.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/luts.12079 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Combined Use of Levodopa/Benserazide and Pramipexole Proves Beneficial for Managing Parkinson's Disease.
Actas Esp Psiquiatr
December 2024
Department of Neurology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, 210003 Nanjing, Jiangsu, China.
Background: Parkinson's disease (PD), a prevalent neurological condition, is characterized by the progressive degeneration of dopamine-producing neurons, leading to motor dysfunction and non-motor symptoms. Therefore, this study aimed to evaluate the impact of combining levodopa/benserazide with pramipexole on PD patients, focusing on cognitive function, plasma monoamine neurotransmitter levels, and serum growth differentiation factor-15 (GDF-15) and angiopoietin-1 (Ang-1) levels.
Methods: This retrospective study included 120 PD patients admitted to the hospital between January 2021 and January 2023.
Impact of the estrous cycle on brain monoamines and behavioral and respiratory responses to CO in mice.
Pflugers Arch
November 2024
Department of Animal Morphology and Physiology, College of Agricultural and Veterinarian Sciences, São Paulo State University, Rod. Prof. Paulo Donato Castellane S/N, Jaboticabal, SP, 14884-900, Brazil.
Article Synopsis
- - The study examines how the estrous cycle affects the responses of female mice to carbon monoxide (CO), focusing on behaviors, brain chemistry, and physiological changes.
- - While all phases of the estrous cycle resulted in similar escape behaviors in response to CO, the ventilation and metabolic responses varied, notably showing higher ventilation and lower body temperature during hypercapnia.
- - The results indicate hypercapnia triggers panic-like behaviors in female mice and influences their hormone levels, but the phase of the estrous cycle does not alter the behavioral response to CO exposure.
Monoamine transporter ubiquitination and inward-open conformation synergistically maximize transporter endocytosis.
Sci Adv
November 2024
Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Monoamine transporters function in neuronal membranes to control extracellular concentrations of their substrates. Cell-surface expression of transporters is regulated by substrates and intracellular signaling, but the underlying mechanisms remain unclear. Here, we found that substrates of the dopamine transporter (DAT), amphetamine and dopamine, synergize with protein kinase C (PKC)-dependent DAT ubiquitination to markedly elevate clathrin-mediated endocytosis of DAT, which is accompanied by DAT movement out of plasma membrane protrusions with a negative curvature.
View Article and Find Full Text PDFEfficacy and safety of DL-3-N-butylphthalide in the treatment of ischemic poststroke aphasia: A randomized clinical trial.
Ann Clin Transl Neurol
December 2024
Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Article Synopsis
- This study investigates the effectiveness and safety of a drug called DL-3-N-butylphthalein (NBP) in treating poststroke aphasia, which significantly affects communication and daily life for many patients following a stroke.
- Conducted over six months with 118 patients, the results showed that those receiving NBP had better improvements in language skills compared to a placebo group, with no significant increase in liver function issues.
- The findings suggest that NBP may enhance recovery in stroke-related language impairment by boosting levels of certain neurotransmitters, indicating a potential new direction for treatment.
F. prausnitzii potentially modulates the association between citrus intake and depression.
Microbiome
November 2024
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Background: The gut microbiome modulates the effects of diet on host health, but it remains unclear which specific foods and microbial features interact to influence risk of depression. To understand this interplay, we leveraged decades of dietary and depression data from a longitudinal cohort of women (n = 32,427), along with fecal metagenomics and plasma metabolomics from a substudy (n = 207) nested in this cohort, as well as an independent validation cohort of men (n = 307).
Results: We report that citrus intake and its components are prospectively associated with a lower risk of depression and altered abundance of 15 gut microbial species, including enriched Faecalibacterium prausnitzii.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!